# DNV001 Injection in Patients With Hypercholesterolemia

> **NCT07391722** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Hangzhou Dinovate Biotech Co., Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Primary Hypercholesterolemia

## Interventions

- **BIOLOGICAL:** DNV001 Injection
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT07391722
- **Lead sponsor:** Hangzhou Dinovate Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07391722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07391722, "DNV001 Injection in Patients With Hypercholesterolemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07391722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*